Recombinant Human Early Placenta Insulin-Like Peptide/INSL4/Placentin (C-6His)

Recombinant Human Early Placenta Insulin-Like Peptide/INSL4/Placentin (C-6His)

SKU: C988-10ug
Recombinant Human Placentin is produced by our Mammalian expression system and the target gene encoding Ala26-Thr139 is expressed with a 6His tag at the C-terminus. Bon Opus Cat. #C988
  • Accession Number

  • Background

    Early Placenta Insulin-Like Peptide (INSL4) belongs to the insulin family. INSL4 is expressed in the early placental cytotrophoblast and syncytiotrophoblast INSL4 is a secreted protein and a precursor that undergoes post-translational cleavage to produce 3 polypeptide chains, A-C, that form tertiary structures composed of either all three chains, or just the A and B chains. INSL4 plays an important role in the development of trophoblast and in the regulation of bone formation.
  • Expression

    Human Cells
  • Packaging

  • Formulation

    Lyophilized from a 0.2 μm filtered solution of 20mM Tris,150mM NACl,pH 8.0.
  • ALTnames

    Early Placenta Insulin-Like Peptide, EPIL, Insulin-Like Peptide 4, Placentin, INSL4
  • Twitter
  • Facebook
  • LinkedIn

Terms and Conditions  I  Privacy Policy  I  Legal  I  Sitemap ©2020 by Bon Opus Biosciences, LLC.     150 Essex St, Millburn, NJ 07041, USA